Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$8.75|
|52 Week High||CA$6.65|
|52 Week Low||CA$22.40|
|1 Month Change||-7.21%|
|3 Month Change||-38.47%|
|1 Year Change||22.38%|
|3 Year Change||-41.47%|
|5 Year Change||n/a|
|Change since IPO||-43.00%|
Recent News & Updates
Is Greenbrook TMS (TSE:GTMS) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
|GTMS||CA Healthcare||CA Market|
Return vs Industry: GTMS exceeded the Canadian Healthcare industry which returned 3.5% over the past year.
Return vs Market: GTMS underperformed the Canadian Market which returned 33.6% over the past year.
Stable Share Price: GTMS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: GTMS's weekly volatility (8%) has been stable over the past year.
About the Company
Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation therapy, an FDA-cleared non-invasive therapy for the treatment of depression and related psychiatric services. The company operates approximately 128 treatment centers.
Greenbrook TMS Fundamentals Summary
|GTMS fundamental statistics|
Is GTMS overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GTMS income statement (TTM)|
|Cost of Revenue||US$34.91m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-1.71|
|Net Profit Margin||-64.83%|
How did GTMS perform over the long term?See historical performance and comparison
Is Greenbrook TMS undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate GTMS's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate GTMS's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: GTMS is unprofitable, so we can't compare its PE Ratio to the Canadian Healthcare industry average.
PE vs Market: GTMS is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GTMS's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GTMS is overvalued based on its PB Ratio (8x) compared to the CA Healthcare industry average (3x).
How is Greenbrook TMS forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual revenue growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if GTMS's forecast earnings growth is above the savings rate (1.6%).
Earnings vs Market: Insufficient data to determine if GTMS's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: GTMS's revenue (38.3% per year) is forecast to grow faster than the Canadian market (6.7% per year).
High Growth Revenue: GTMS's revenue (38.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GTMS's Return on Equity is forecast to be high in 3 years time
How has Greenbrook TMS performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GTMS is currently unprofitable.
Growing Profit Margin: GTMS is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: GTMS is unprofitable, and losses have increased over the past 5 years at a rate of 59.3% per year.
Accelerating Growth: Unable to compare GTMS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: GTMS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (56.6%).
Return on Equity
High ROE: GTMS has a negative Return on Equity (-212.13%), as it is currently unprofitable.
How is Greenbrook TMS's financial position?
Financial Position Analysis
Short Term Liabilities: GTMS's short term assets ($32.2M) exceed its short term liabilities ($17.9M).
Long Term Liabilities: GTMS's short term assets ($32.2M) do not cover its long term liabilities ($37.1M).
Debt to Equity History and Analysis
Debt Level: GTMS's debt to equity ratio (112.7%) is considered high.
Reducing Debt: GTMS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GTMS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GTMS has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 27.9% each year.
What is Greenbrook TMS current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate GTMS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GTMS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if GTMS's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GTMS's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GTMS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Bill Leonard (56 yo)
Mr. William P. Leonard, also knonw as Bill, has been the President and Chief Executive Officer of Greenbrook TMS Inc. since 2011 and serves as its Director since February 2018. Mr. Leonard is the President...
CEO Compensation Analysis
Compensation vs Market: Bill's total compensation ($USD705.00K) is above average for companies of similar size in the Canadian market ($USD164.84K).
Compensation vs Earnings: Bill's compensation has increased whilst the company is unprofitable.
Experienced Management: GTMS's management team is considered experienced (3.7 years average tenure).
Experienced Board: GTMS's board of directors are considered experienced (3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.8%.
Greenbrook TMS Inc.'s employee growth, exchange listings and data sources
- Name: Greenbrook TMS Inc.
- Ticker: GTMS
- Exchange: TSX
- Founded: 2011
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: CA$155.766m
- Shares outstanding: 17.80m
- Website: https://www.greenbrooktms.com
Number of Employees
- Greenbrook TMS Inc.
- 890 Yonge Street
- 7th Floor
- M4W 3P4
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/24 22:13|
|End of Day Share Price||2021/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.